drugset / Trial / NCT01941901

Calcium Electroporation for Treatment of Cutaneous Metastases

NCT01941901

Phase 2 Completed 7 enrolled Herlev Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of calcium electroporation on cutaneous metastases, and compare calcium electroporation with standard treatment: electrochemotherapy.

Timeline

Start
2013-09
Primary completion
2016-09
Completion
2017-01-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bleomycin Unknown 1000 iu Other
Subject Calcium Chloride Unknown 9 mg/ml Other

Indications

No indication recorded.